Targeting BCL2 in Waldenström macroglobulinemia: from biology to treatment management. [PDF]
Kalafati E, Kastritis E, Bagratuni T.
europepmc +1 more source
Biochemical analysis reveals aberrant and variable Immunoglobulin M composition in Waldenström macroglobulinemia and IgM monoclonal gammopathy of unknown significance. [PDF]
Oskam N +9 more
europepmc +1 more source
Amyloidosis-Related Cardiomyopathy Revealing Waldenstrom Macroglobulinemia: A Case Report. [PDF]
Tariq M +6 more
europepmc +1 more source
Waldenström Macroglobulinemia and Chronic Myelomonocytic Leukemia: Case Report and Literature Review. [PDF]
Pan Y, Wang Y, Wang Q.
europepmc +1 more source
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia. [PDF]
Branagan AR +30 more
europepmc +1 more source
Progression of IgM Monoclonal Gammopathy of Renal Significance (MGRS) to Symptomatic Waldenström Macroglobulinemia: A Case Report. [PDF]
Ito K +3 more
europepmc +1 more source
From interference to insight: pseudo-lipidemia led to the diagnosis of Waldenström macroglobulinemia. [PDF]
Wang D +9 more
europepmc +1 more source
Waldenström Macroglobulinemia: The Role of TP53 Mutations in Disease Progression and Therapeutic Response. [PDF]
Kampitsi DD +5 more
europepmc +1 more source
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 2- Focus on Therapy. [PDF]
Bibas M, Sarosiek S, Castillo JJ.
europepmc +1 more source

